How Low Will It Go?

Discussion in 'Heron Therapeutics' started by anonymous, Jul 8, 2017 at 5:22 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Heron (AP) is a company that I have been following for several years. This stock continues to spiral down and disappoint. Anyone know the reason for this kind of drop in a company that had high hopes?
     

  2. anonymous

    anonymous Guest

    My guess is below 10.85 by October
     
  3. anonymous

    anonymous Guest

    The company is currently sustaining losses. For the first quarter of the year, Heron reported its net loss at $50.3 million, up from $33.4 million in loss it had incurred for the corresponding quarter of the previous year. These mounting losses are likely to take their toll on the company’s stock market performance, which already looks rather worrisome with the price losing over 30 percent of its value in the past 12 months.
     
  4. anonymous

    anonymous Guest

    Under 9.00 by November as data read out will not be positive
     
  5. anonymous

    anonymous Guest

    A company like Tesaro puts Heron to shame
     
  6. anonymous

    anonymous Guest

    Lol data for wut? Idiot.
     
  7. anonymous

    anonymous Guest

    This is the worst place on earth....... words can't explain the lack of leadership from the top.
     
  8. anonymous

    anonymous Guest

    Please someone desperate buy this shitty drug and pipeline. We will accept any offer at this point before we go bankrupt.
     
  9. anonymous

    anonymous Guest

    Heron stock had a rise 2 weeks ago but now seems to continue to go back down. Any predictions on how low it will go?
     
  10. anonymous

    anonymous Guest

    How much lower could it possibly go?
     
  11. anonymous

    anonymous Guest

    Leverage & Liquidity
    HRTX-US would seem to have a hard time raising additional debt.

    • With debt at a relatively low 4.23% of its enterprise value compared to an overall benchmark of 25% (Note: The peer median is currently 4.23%), and relatively tight interest coverage level of -61.23x, HRTX-US would have a hard time raising much additional debt. Thus, the company is classified as having Limited Flexibility when it comes to raising more debt.
    • Of the 9 chosen peers for the company, only 6 of the stocks have an outstanding debt balance. Companies with no debt include INSY-US and SRDX-US.
    HRTX-US has maintained its Constrained profile from the recent year-end.

    • HRTX-US‘s interest coverage is greater than (but within one standard deviation of) its five-year average interest coverage of -70.44x.
    • Though its interest coverage has remained relatively stable at -61.23x compared to 2016, its peer median has decreased to -4.17x from -2.91x during this period.
    • Interest coverage rose 1.26 points relative to peers.
    • HRTX-US‘s debt-EV has declined 6.00 percentage points from last year’s high but remains above its five-year average debt-EV of 2.48.
    • The decrease in its debt-EV to 4.23% from 10.23% (in 2016) was also accompanied by a decrease in its peer median during this period to 4.23% from 9.48%.
    • Relative to peers, debt-EV fell 0.75 percentage points.